文章预览
📢 文末扫码进裙，免费领取双语精读讲义 AI will boost drug development in 2025 Software-inspired medicines are getting closer to prime time The Economist Science & technology Dec 20, 2024 | 758words | ★★★ ★ ☆ Progress in computing has long been described by Moore’s law, a rule of thumb which says that the cost of processing power falls by half roughly every two years. The pharmaceutical industry follows an opposite rule. Its version, called Eroom’s law (“Moore” spelled backwards), posits that the cost of developing a new drug doubles roughly every nine years. In the 1960s $1bn (at 2008 prices) spent in research and development (R ) yielded about ten new drugs. Today the same $1bn isn’t enough to produce even one. On average, it now takes ten years and more than $2bn to develop a drug from start to finish. The risks are also steep—less than one-tenth of drug candidates that enter clinical trials are approved by regulators. In the past decade
………………………………
